From data to decisions: How AI is acelerating Clinical Trial & Drug development

Unlocking the Future of Clinical Trials: AI‑Driven Insights for Smarter, Faster Drug DevelopmentArtificial intelligence is rapidly transforming the landscape of clinical research — from protocol design and patient recruitment to data interpretation and operational decision‑making. As the industry faces increasing complexity, rising costs, and growing expectations for speed and precision, AI is emerging not just as a tool, but as a strategic advantage.

Join Kevin Yiming Lu and PeiYun Christelle Tan for an in‑depth session exploring how AI and advanced analytics are reshaping the way clinical trials are planned, executed, and optimized. This event brings together real‑world examples, practical frameworks, and forward‑looking perspectives on how organizations can harness AI to drive better outcomes across the drug development lifecycle.

What you’ll gain from this session

• A clear understanding of how AI is being applied today in clinical trial design, feasibility assessment, and operational forecasting.